STOCK TITAN

Gabelli Entities Hold 287,926 DALN Shares; 10% Poison Pill Cited

(Neutral)
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Gabelli-affiliated investors disclosed a combined 287,926 shares of DallasNews Corp Series A common stock, representing 6.08% of the 4,739,025 shares outstanding. The filing details individual holdings: Gabelli Funds 128,026 shares (2.70%), Gabelli & Co Investment Advisers/GCIA 102,400 shares (2.16%), GAMCO 47,000 shares (0.99%) and Teton Advisors 10,500 shares (0.22%). The group reports using approximately $540,368 to buy additional shares, including client funds. The filing notes the issuer adopted a 10% poison pill and the reporting persons have not decided how to vote at the issuer's special meeting involving a proposed acquisition by Hearst; they continue to evaluate the situation.

Positive

  • Transparent breakdown of holdings showing aggregate 287,926 shares (6.08%) and individual positions by reporting person
  • Disclosure of funds used to acquire additional shares (approximately $540,368), including client funds, clarifies source of purchases
  • Filing of long-form Schedule 13D ensures compliance and transparency despite potential eligibility for a short form

Negative

  • Issuer adopted a 10% poison pill, which the filers state is inconsistent with their proxy voting guidelines
  • Reporting persons have not decided how to vote on the proposed acquisition, creating uncertainty for other shareholders
  • Significant portion of purchases were made with client funds, which may complicate alignment between principals and advisory clients

Insights

TL;DR Gabelli-related entities hold a meaningful minority stake (6.08%); holdings are split across affiliated advisers and funds.

The disclosed 6.08% position is large enough to warrant market attention but not controlling. Concentration by Gabelli Funds and GCIA (combined ~4.86%) signals coordinated exposure through affiliated investment vehicles. The aggregate cash deployed of $540,368 to acquire additional shares is disclosed and purchases include client funds, indicating portfolio-level activity rather than solely principal accumulation. Absent changes to voting intentions, the stake suggests potential engagement but not an outright control attempt.

TL;DR The filing highlights governance friction: the issuer adopted a 10% poison pill and Gabelli-affiliated holders are evaluating their voting decisions.

The adoption of a 10% poison pill is expressly noted and cited as inconsistent with GAMCO proxy guidelines. The reporting persons explicitly state they have not determined how they will vote on the proposed acquisition and will consider the poison pill among other factors. This disclosure is material to shareholder voting dynamics and indicates potential proxy deliberation rather than an immediate activist escalation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How many DallasNews (DALN) shares do Gabelli-affiliated reporting persons own?

They report an aggregate of 287,926 shares, representing 6.08% of the 4,739,025 shares outstanding as reported by the issuer.

Which Gabelli entities hold the largest DALN positions?

Gabelli Funds holds 128,026 shares (2.70%) and Gabelli & Co Investment Advisers/GCIA holds 102,400 shares (2.16%).

Did the reporting persons buy additional DALN shares and what funds were used?

Yes; they used approximately $540,368 to purchase additional securities. GAMCO, Gabelli Funds and GCIA used client funds for portions of those purchases.

What corporate action by DallasNews is highlighted in the filing?

The filing notes the issuer adopted a 10% poison pill applicable to non-13G filers, and the reporting persons view it as inconsistent with GAMCO proxy guidelines.

Have the reporting persons decided how to vote on the proposed acquisition by Hearst?

No; the reporting persons state they have not yet reached a conclusion on how they intend to vote and are continuing to evaluate the dynamics.

What percentage of DALN does GAMCO itself hold?

GAMCO Asset Management Inc. reports 47,000 shares, representing 0.99% of the class.





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


GAMCO INVESTORS, INC. ET AL
Signature:PETER D. GOLDSTEIN
Name/Title:GENERAL COUNSEL
Date:09/10/2025
GABELLI FUNDS LLC
Signature:DAVID GOLDMAN
Name/Title:GENERAL COUNSEL
Date:09/10/2025
GAMCO Asset Management Inc.
Signature:DOUGLAS R. JAMIESON
Name/Title:PRESIDENT
Date:09/10/2025
GABELLI & Co INVESTMENT ADVISERS, INC.
Signature:DOUGLAS R. JAMIESON
Name/Title:PRESIDENT
Date:09/10/2025
Teton Advisors, Inc.
Signature:DAVID GOLDMAN
Name/Title:COUNSEL
Date:09/10/2025
GGCP, INC.
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:09/10/2025
Associated Capital Group, Inc.
Signature:PETER D. GOLDSTEIN
Name/Title:CHIEF LEGAL OFFICER
Date:09/10/2025
GABELLI MARIO J
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:09/10/2025